Cargando…

Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network

BACKGROUND: Remarkably, the anti-cancer efficacy of immunotherapy in lung adenocarcinoma (LUAD) has been demonstrated. However, predicting the beneficiaries of this expensive treatment is still a challenge. MATERIALS AND METHODS: A group of patients (N = 250) diagnosed with LUAD and receiving immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Fu, Siyun, Gao, Xiang, Lu, Zhendong, Jin, Renjing, Qin, Na, Zhang, Xinyong, Wu, Yuhua, Li, Weiying, Wang, Jinghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086240/ https://www.ncbi.nlm.nih.gov/pubmed/37056768 http://dx.doi.org/10.3389/fimmu.2023.1141408

Ejemplares similares

Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network
por: Li, Siqi, et al.
Publicado: (2022)

Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
por: Ge, Yang, et al.
Publicado: (2023)

PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer
por: Gao, Xiang, et al.
Publicado: (2023)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib
por: Zhang, Xinyong, et al.
Publicado: (2020)

Crizotinib versus platinum‐based double‐agent chemotherapy as the first line treatment in advanced anaplastic lymphoma kinase‐positive lung adenocarcinoma
por: Zhang, Quan, et al.
Publicado: (2015)

Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma
por: Zhao, Fangchao , et al.
Publicado: (2022)

Neural network-based model for evaluating inert nodules and volume doubling time in T1 lung adenocarcinoma: a nested case−control study
por: Wang, Bing, et al.
Publicado: (2023)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy
por: Zhu, Mingyu, et al.
Publicado: (2022)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Transcriptional patterns reveal tumor histologic heterogeneity and immunotherapy response in lung adenocarcinoma
por: Jiao, Mengxue, et al.
Publicado: (2022)

Characterization of m(6)A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma
por: Zhu, Minggao, et al.
Publicado: (2021)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

The future of combination immunotherapy in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2023)

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Comprehensive analyses for the coagulation and macrophage-related genes to reveal their joint roles in the prognosis and immunotherapy of lung adenocarcinoma patients
por: Li, Zhuoqi, et al.
Publicado: (2023)

BTG2 and SerpinB5, a novel gene pair to evaluate the prognosis of lung adenocarcinoma
por: Yang, Wanting, et al.
Publicado: (2023)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Nanomaterials: A powerful tool for tumor immunotherapy
por: Chen, Ziyin, et al.
Publicado: (2022)

Exosomes: A potential tool for immunotherapy of ovarian cancer
por: Gong, Xiangjin, et al.
Publicado: (2023)

ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis
por: Wu, Lei, et al.
Publicado: (2022)

Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy
por: Gao, Xingchun, et al.
Publicado: (2017)

Evaluation of immunotherapy efficacy in gynecologic cancer
por: Jiang, Genyi, et al.
Publicado: (2023)

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma
por: Li, Chao, et al.
Publicado: (2022)

Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2023)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
por: Huang, Jihong, et al.
Publicado: (2022)

Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma
por: Zhao, Yue, et al.
Publicado: (2022)

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy
por: Zhou, Xiaogang, et al.
Publicado: (2021)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2023)

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
por: Schmiechen, Zoe C., et al.
Publicado: (2021)

CD8(+) T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2022)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

SIRGs score may be a predictor of prognosis and immunotherapy response for esophagogastric junction adenocarcinoma
por: OuYang, Li-Ying, et al.
Publicado: (2022)

Efficacy of radiotherapy in combination with first-line immunotherapy and chemotherapy for advanced lung squamous cell carcinoma: a propensity score analysis
por: Qin, Jian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oha6abl3t0kfvv2qn19rdin79o